Tag:

social media

Latest Headlines

Latest Headlines

Pharma continues to grapple with trial participants' use of social media

While it is years now since clinical trial participants started talking about their experiences online, the industry is still searching for the best way to approach the phenomenon. And with pharma needing to improve the clinical trial process, the onus is on the industry to find systems that not only manage the negative implications of social media, but tap into its power, too.

Tufts survey shows social media still on fringes of clinical trials

It is almost four years since Facebook passed 500 million users. And while the role of it and other social media in clinical trials has generated lots of media coverage and conference chatter, the industry is yet to fully embrace the tools. Survey data published this week show just how there is to go.

Great expectations: Patients think pharma owes them apps, rewards, and more

It's not just about the pill anymore. That's a statement fast becoming a mantra in the pharma business. But while drugmakers experiment with apps and text reminders and copay discounts, patients are coming to expect all of that and more.

For once, the FDA writes up pharma for a simple Facebook violation

The FDA has slapped another drugmaker on Facebook. And this time, the agency's complaints don't raise thorny questions or create new gray areas. The untitled letter to Institut Biochimique and its U.S. partner Akrimax Pharmaceuticals is about as garden-variety as they come.

Eli Lilly begins sharing photos on Instagram

The account--elilillyco--has posted old photographs of Lilly's facilities and researchers alongside pictures of what its current staff are doing.

Report: Big Data, social media and mobile double their share of biopharma marketing mix

Over the past decade a plethora of digital formats have begun competing with print, television, radio and conferences for biopharma marketeers' budgets. And while initial uptake was slow, a survey has now found Big Data, social media and mobile have doubled their share of the marketing mix since 2012.

Twitter praises Boehringer for social media savvy

Which pharma companies are getting it right when it comes to social media? As far as Twitter is concerned, Boehringer Ingelheim is up there.

Twitter explains how Boehringer is winning on social media

Biopharma has encountered more critics than cheerleaders as it has cautiously edged into social media, but Boehringer Ingelheim has recently won a high-profile supporter: Twitter. In a case study, the social network praised Boehringer's use of its platform.

The top 10 pharma companies in social media

Chatting with the public is not in pharma's comfort zone. Drugmakers are adept at the one-way communication known as direct-to-consumer advertising, and some of them deal well with the media....

Report: Pharma is missing a Big Data opportunity by ignoring social media

Inherent conservatism and a lack of regulatory guidance have caused pharma to edge slowly onto social media platforms. Yet patients still talk about their health online. Should drugmakers be listening?